Cargando…
Managing argatroban in heparin‐induced thrombocytopenia: A retrospective analysis of 729 treatment days in 32 patients with confirmed heparin‐induced thrombocytopenia
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324832/ https://www.ncbi.nlm.nih.gov/pubmed/35358358 http://dx.doi.org/10.1111/bjh.18120 |
| _version_ | 1784756895845711872 |
|---|---|
| author | Marchetti, Matteo Barelli, Stefano Gleich, Tobias Gomez, Francisco J. Goodyer, Matthew Grandoni, Francesco Alberio, Lorenzo |
| author_facet | Marchetti, Matteo Barelli, Stefano Gleich, Tobias Gomez, Francisco J. Goodyer, Matthew Grandoni, Francesco Alberio, Lorenzo |
| author_sort | Marchetti, Matteo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9324832 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93248322022-07-30 Managing argatroban in heparin‐induced thrombocytopenia: A retrospective analysis of 729 treatment days in 32 patients with confirmed heparin‐induced thrombocytopenia Marchetti, Matteo Barelli, Stefano Gleich, Tobias Gomez, Francisco J. Goodyer, Matthew Grandoni, Francesco Alberio, Lorenzo Br J Haematol Platelets, Thrombosis and Haemostasis John Wiley and Sons Inc. 2022-03-31 2022-06 /pmc/articles/PMC9324832/ /pubmed/35358358 http://dx.doi.org/10.1111/bjh.18120 Text en © 2022 The Authors. British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Platelets, Thrombosis and Haemostasis Marchetti, Matteo Barelli, Stefano Gleich, Tobias Gomez, Francisco J. Goodyer, Matthew Grandoni, Francesco Alberio, Lorenzo Managing argatroban in heparin‐induced thrombocytopenia: A retrospective analysis of 729 treatment days in 32 patients with confirmed heparin‐induced thrombocytopenia |
| title | Managing argatroban in heparin‐induced thrombocytopenia: A retrospective analysis of 729 treatment days in 32 patients with confirmed heparin‐induced thrombocytopenia |
| title_full | Managing argatroban in heparin‐induced thrombocytopenia: A retrospective analysis of 729 treatment days in 32 patients with confirmed heparin‐induced thrombocytopenia |
| title_fullStr | Managing argatroban in heparin‐induced thrombocytopenia: A retrospective analysis of 729 treatment days in 32 patients with confirmed heparin‐induced thrombocytopenia |
| title_full_unstemmed | Managing argatroban in heparin‐induced thrombocytopenia: A retrospective analysis of 729 treatment days in 32 patients with confirmed heparin‐induced thrombocytopenia |
| title_short | Managing argatroban in heparin‐induced thrombocytopenia: A retrospective analysis of 729 treatment days in 32 patients with confirmed heparin‐induced thrombocytopenia |
| title_sort | managing argatroban in heparin‐induced thrombocytopenia: a retrospective analysis of 729 treatment days in 32 patients with confirmed heparin‐induced thrombocytopenia |
| topic | Platelets, Thrombosis and Haemostasis |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324832/ https://www.ncbi.nlm.nih.gov/pubmed/35358358 http://dx.doi.org/10.1111/bjh.18120 |
| work_keys_str_mv | AT marchettimatteo managingargatrobaninheparininducedthrombocytopeniaaretrospectiveanalysisof729treatmentdaysin32patientswithconfirmedheparininducedthrombocytopenia AT barellistefano managingargatrobaninheparininducedthrombocytopeniaaretrospectiveanalysisof729treatmentdaysin32patientswithconfirmedheparininducedthrombocytopenia AT gleichtobias managingargatrobaninheparininducedthrombocytopeniaaretrospectiveanalysisof729treatmentdaysin32patientswithconfirmedheparininducedthrombocytopenia AT gomezfranciscoj managingargatrobaninheparininducedthrombocytopeniaaretrospectiveanalysisof729treatmentdaysin32patientswithconfirmedheparininducedthrombocytopenia AT goodyermatthew managingargatrobaninheparininducedthrombocytopeniaaretrospectiveanalysisof729treatmentdaysin32patientswithconfirmedheparininducedthrombocytopenia AT grandonifrancesco managingargatrobaninheparininducedthrombocytopeniaaretrospectiveanalysisof729treatmentdaysin32patientswithconfirmedheparininducedthrombocytopenia AT alberiolorenzo managingargatrobaninheparininducedthrombocytopeniaaretrospectiveanalysisof729treatmentdaysin32patientswithconfirmedheparininducedthrombocytopenia |